SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000819050-21-000093
Filing Date
2021-06-14
Accepted
2021-06-14 16:47:14
Documents
1
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162370361611445.html 4  
1 FORM 4 wf-form4_162370361611445.xml 4 3768
  Complete submission text file 0000819050-21-000093.txt   5270
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PALIDADE CAPITAL ONE BRIDGE PLAZA NORTH #695 FORT LEE NJ 07024
Business Address
VERU DENNISON T (Reporting) CIK: 0001225341 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21088 | Film No.: 211015143